Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics

  1. Lipton, A.
  2. Fizazi, K.
  3. Stopeck, A.T.
  4. Henry, D.H.
  5. Smith, M.R.
  6. Shore, N.
  7. Martin, M.
  8. Vadhan-Raj, S.
  9. Brown, J.E.
  10. Richardson, G.E.
  11. Saad, F.
  12. Yardley, D.A.
  13. Zhou, K.
  14. Balakumaran, A.
  15. Braun, A.
Revista:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Any de publicació: 2016

Volum: 53

Pàgines: 75-83

Tipus: Article

DOI: 10.1016/J.EJCA.2015.09.011 GOOGLE SCHOLAR lock_openAccés obert editor

Objectius de Desenvolupament Sostenible

Font de les dades: Scopus